Patents Represented by Attorney Robert L. Niblack
  • Patent number: 4174342
    Abstract: By the addition of a relatively small amount of N-(acenaphthenyl)maleimides carrying optional substituents, synthetic films, plastics, woven or knitted synthetic or cellulosic fabrics, or paint can be protected against fungal and bacterial deterioration.
    Type: Grant
    Filed: March 27, 1978
    Date of Patent: November 13, 1979
    Assignee: Abbott Laboratories
    Inventors: Jorge P. Li, Frank C. Becker
  • Patent number: 4173564
    Abstract: This invention provides 4-N-acylfortimicin B derivatives of the structure ##STR1## wherein R is acyl, aminoacyl, N-monoloweralkylaminoacyl, N,N-diloweralkylaminoacyl, hydroxy-substituted aminoacyl, or substituted aminoacyl of the formula ##STR2## where R.sup.1 is an acyl radical derived from an amino acid or a short peptide, and the pharmaceutically acceptable salts thereof.The compounds are useful as intermediates for preparing 4-N-alkyl or substituted alkylfortimicin B derivatives. In addition to their utility as intermediates, some of the compounds of this invention are also useful as antimicrobial agents.
    Type: Grant
    Filed: November 1, 1978
    Date of Patent: November 6, 1979
    Assignee: Abbott Laboratories
    Inventors: John S. Tadanier, Jerry R. Martin, Paul Kurath
  • Patent number: 4173222
    Abstract: An apparatus for administering parenteral liquids from a parenteral fluid container which provides a sufficient quantity of parenteral liquid to be administered at a slower than normal rate so as to afford a keep-vein-open (KVO) means. The apparatus utilizes a first orifice to afford a faster flow rate than a second orifice spaced away from the first orifice. The preferred means for regulating different flow rates of fluid through the two orifices are the dimensions of the orifices and filters having different mesh sizes. When the parenteral liquid is maintained in the reservoir in contact with the first orifice with the faster flow rate, liquid will pass through both orifices at a predetermined regular rate. When liquid no longer contacts the first orifice, as when the fluid container is depleted of liquid, the second orifice then comes into effect to afford a slower rate of liquid until a new container can be supplied.
    Type: Grant
    Filed: August 19, 1976
    Date of Patent: November 6, 1979
    Assignee: Abbott Laboratories
    Inventor: Andrew J. Muetterties
  • Patent number: 4172943
    Abstract: A compound of the formula ##STR1## wherein R.sub.1 is H or loweralkyl; R.sub.2 is H, loweralkyl, phenyl or substituted phenyl; R is C.sub.3 -C.sub.20 alkyl, phenyl alkyl or substituted phenyl alkyl; R.sub.3 is H or ##STR2## where X is a straight or branched chain alkylene group of 3 to 4 carbon atoms, and R.sub.4 and R.sub.5 are the same or different members of the group consisting of H or loweralkyl; or R.sub.4 and R.sub.5 taken together form a 6- or 6- member heterocyclic ring and containing no more than one additional heterocyclic atom, with or without .alpha.-loweralkyl substituents, and the acid addition salts thereof.The compounds of this invention are useful as analgesics, tranquilizers, sedative-hypnotics and anti-glaucoma agents.
    Type: Grant
    Filed: August 4, 1978
    Date of Patent: October 30, 1979
    Assignee: Abbott Laboratories
    Inventors: Harold E. Zaugg, Cheuk M. Lee
  • Patent number: 4171698
    Abstract: A prefilled, ready to use, disposable syringe wherein a fluid medicament and a diluent therefor are sealed in two separate telescoping syringe barrels. A medicinal powder is sealed in an outer barrel adjacent the nozzle section by means of a pierceable stopper and the diluent is sealed in an inner barrel between another pierceable stopper and a plunger stopper. A double-pointed cannula is positioned between the two pierceable stoppers by means of a telescoping guide arrangement. Movement of the plunger stopper inwardly in the inner barrel initially effects a piercing of both pierceable stoppers and intermixing of the medicinal powder with the diluent. Continued movement of the plunger stopper will expel the mixed medicament from the syringe.
    Type: Grant
    Filed: August 15, 1977
    Date of Patent: October 23, 1979
    Assignee: Abbott Laboratories
    Inventor: Joseph N. Genese
  • Patent number: 4171204
    Abstract: A method for analyzing blood serum or plasma wherein the blood serum or plasma is treated with about 1.4 or more volumes of acetonitrile, propionitrile, tetrahydrofuran or mixtures thereof to precipitate proteins and to provide a supernatant. The separated supernatant is subsequently examined for a component of interest.
    Type: Grant
    Filed: September 1, 1978
    Date of Patent: October 16, 1979
    Assignee: Abbott Laboratories
    Inventors: Kathryn S. Schwenzer, Susan E. Magic
  • Patent number: 4171367
    Abstract: Described are compounds of the formula ##STR1## wherein R.sup.1 and R.sup.2 are hydrogen, alkyl, cycloalkyl, and aryl, R.sup.3 is hydrogen or halogen, and R.sup.4 is hydrogen or acyl, and pharmaceutically acceptable acid addition salts thereof. R.sup.3 can be located in the 4 or 5 position as can the amino imidazoline group. The compounds are useful as anti-inflammatory agents.
    Type: Grant
    Filed: February 18, 1977
    Date of Patent: October 16, 1979
    Assignee: Abbott Laboratories
    Inventors: Martin Winn, Carl W. Nordeen
  • Patent number: 4169475
    Abstract: An additive transfer device for storing and transferring of a medicament to a solution container such as an I.V. bag having an exposed port. The transfer device includes a vial-type container having a slidable pierceable sealing element. A holder member secures a piercing cannular member and the holder has a guide means at one end to fit around th exposed port of the I.V. bag. A cover extends over the guide means and is in sealing contact with the vial. Activating means are provided in conjunction with the cover, the holder and the vial to effect movement of the holder member toward the vial and piercing of the vial stopper by one end of the cannula. With a piercing of the I.V. port by means of the other pointed end of the cannula, communication can be made between the additive container and the I.V. bag.
    Type: Grant
    Filed: December 8, 1977
    Date of Patent: October 2, 1979
    Assignee: Abbott Laboratories
    Inventor: Joseph N. Genese
  • Patent number: 4169198
    Abstract: A new fortimicin antibiotic, 2-deoxyfortimicin B, intermediates useful in the preparation of the compound, methods of making and using the compound and compositions containing 2-deoxyfortimicin B.
    Type: Grant
    Filed: December 21, 1977
    Date of Patent: September 25, 1979
    Assignee: Abbott Laboratories
    Inventors: Jerry R. Martin, John S. Tadanier, Paulette Collum
  • Patent number: 4168024
    Abstract: Carrier comprising a unitary polystyrene container having posts extending divergently out from the container in nonvertical directions and a carrying strap or handle affixed to each post substantially perpendicular to the axis thereof. The carrier is useful as an emergency medical kit.
    Type: Grant
    Filed: February 10, 1978
    Date of Patent: September 18, 1979
    Assignee: Abbott Laboratories
    Inventor: Herbert F. D'Alo
  • Patent number: 4167565
    Abstract: A method of controlling undesired animals including rodents, coyotes and birds which comprises making available to said animals an edible composition containing, as the active ingredient, a lethal dose of a compound represented by formula ##STR1## wherein R is H, loweralkyl or acetyl; R.sub.1 is H or acetyl; R.sub.2 is H, Cl or NH.sub.2 ; R.sub.3 is H, loweralkyl, alkoxy, cycloalkyl or hydroxyalkyl; R.sub.4 and R.sub.5 are each H, acetyl or propionyl, or when taken together form a p-chlorobenzylidene, a carbonate or an ethoxymethylene moiety; in a suitable carrier.
    Type: Grant
    Filed: November 8, 1976
    Date of Patent: September 11, 1979
    Assignee: Abbott Laboratories
    Inventors: Herman H. Stein, Raj N. Prasad, Karin R. Tietje, Anthony K. L. Fung
  • Patent number: 4166819
    Abstract: This invention provides 4-aroyl substituted phenoxy acetic acids and tetrazoles of the formula ##STR1## wherein R is a phenyl ring, a substituted phenyl ring, or naphthyl; R.sub.1 is --CH.sub.2 COOH or methyl tetrazole, and X.sub.1 and X.sub.2 are each a halogen or loweralkyl, or when taken together form with the two attached carbons a phenyl ring.These compounds are useful as antihypertensive agents, diuretics and uricosuric agents.
    Type: Grant
    Filed: September 6, 1977
    Date of Patent: September 4, 1979
    Assignee: Abbott Laboratories
    Inventors: Peter H. Jones, Dilbagh S. Bariana, Anthony K. L. Fung, Yvonne C. Martin, Jaroslav Kyncl, Amrit Lall
  • Patent number: 4166825
    Abstract: The present invention encompasses acid addition salts of a compound of the formula ##STR1## wherein: R.sub.1 represents phenylsulfonyl, benzoyl, carbobenzoxy, and the halo, loweralkyl having 1-4 carbon atoms, loweralkoxy having 1-3 carbon atoms, phenyl, or hydroxy substituted derivatives thereof; or alkanoyl having 2-12 carbon atoms; R.sub.2 represents alkyl having 1-10 carbon atoms, alkoxyalkyl having 2-6 carbon atoms, cycloalkyl having 5-7 carbon atoms, benzyl and the halo, loweralkyl having 1-4 carbon atoms, loweralkoxy having 1-3 carbon atoms, carboxy, hydroxy, or substituted derivatives thereof; R.sub.3 represents hydrogen or guanyl, and m is 3 or 4.Compounds of the present invention are useful as analytical reagents. Enzymatic hydrolysis provides --S--R.sub.2 which can be further reacted with 5,5'-dithiobis (2-nitrobenzoic acid) to provide a colored product by which the enzyme concentration can be determined spectrophotometrically.
    Type: Grant
    Filed: August 17, 1978
    Date of Patent: September 4, 1979
    Assignee: Abbott Laboratories
    Inventors: Jacob J. Plattner, Houston F. Voss, Susan E. Magic
  • Patent number: 4162912
    Abstract: Disclosed is a composition and method for controlling milkweed vine by applying Araujio mosaic virus to the vine.
    Type: Grant
    Filed: February 7, 1978
    Date of Patent: July 31, 1979
    Assignee: Raghavan Charudattan
    Inventor: Raghavan Charudattan
  • Patent number: 4161178
    Abstract: An additive transfer device for storing and transferring of a medicament to a solution container such as an I.V. bag having an exposed port. The transfer device is accommodated in the neck of an additive container having a pierceable sealing element. A holder member for a doubled pointed end piercing member engages a cap covering the tubular neck and affords a movement of the piercing member toward the sealing element to pierce it. Guide means extend from the holder member and fit over the tubular port of the I.V. bag. When the opposing pointed end of the piercing element is pierced through the I.V. port, communication can be made between the additive container and the I.V. bag. In a preferred manner, the contents of the additive container are expelled by collapsing the walls which force the medicament into the I.V. bag by means of the piercing element.
    Type: Grant
    Filed: December 8, 1977
    Date of Patent: July 17, 1979
    Assignee: Abbott Laboratories
    Inventor: Joseph N. Genese
  • Patent number: 4161488
    Abstract: The present invention encompasses the acid addition salts of a compound of the formula ##STR1## wherein R.sub.1 represents phenylsulfonyl, benzoyl, carbobenzoxy, and the halo, loweralkyl having 1-4 carbon atoms, loweralkoxy having 1-3 carbon atoms, phenyl, or hydroxy substituted derivatives thereof; or alkanoyl having 2-12 carbon atoms; and R.sub.2 represents alkyl having 1-10 carbon atoms, or alkoxyalkyl having 2-6 carbon atoms, cycloalkyl having 5-7 carbon atoms, or benzyl and the halo, loweralkyl having 1-4 carbon atoms, loweralkoxy having 1-3 carbon atoms, hydroxy, carboxy, or phenyl substituted derivatives thereof.Compounds of the present invention are useful as analytical reagents. Enzymatic hydrolysis provides --S--R.sub.2 which can be further reacted with 5,5'-dithiobis (2-nitrobenzoic acid) to provide a colored product by which the enzyme concentration can be determined spectrophotometrically.
    Type: Grant
    Filed: August 17, 1978
    Date of Patent: July 17, 1979
    Assignee: Abbott Laboratories
    Inventors: Jacob J. Plattner, Houston F. Voss, Susan E. Magic
  • Patent number: 4160451
    Abstract: A unidirectional, needle outside, reel-type catheter placement unit is disclosed. The unidirectional unit obviates severing of the catheter by the needle, which can occur when the catheter is retracted in bidirectional units. Preferably, the catheter placement unit comprises an overcap or cover which is only coupled to the reel of the reel-type catheter placement unit by a ball clutch when the overcap is rotated in a direction that advances the catheter from the unit.
    Type: Grant
    Filed: November 25, 1977
    Date of Patent: July 10, 1979
    Assignee: Abbott Laboratories
    Inventor: Richard M. Chittenden
  • Patent number: 4158362
    Abstract: A unidirectionally valved drip chamber, inlet port assembly useful for liquid collection containers, e.g., urinary collection bags, or other containers requiring antireflux protection is disclosed. The assembly comprises a flexible, hollow, substantially frusto-conical unidirectional valve fixedly mounted between the inlet and outlet of the assembly. The valve has a closed top and open bottom and is normally closed against a complementary substantially frusto-conical valve seat. The conical wall of the valve flexes away from the valve seat to allow liquid to flow from the inlet to the outlet. Liquid flowing from the outlet towards the inlet forces the valve more firmly against the valve seat so that the valve remains closed to such reverse or reflux flow.
    Type: Grant
    Filed: August 23, 1977
    Date of Patent: June 19, 1979
    Assignee: Abbott Laboratories
    Inventors: Andrew M. Durrett, Kenneth E. Pawlak
  • Patent number: 4156684
    Abstract: Gibberellin A.sub.4 can be separated from the mixture of gibberellin A.sub.4 /A.sub.7 by placing a dilute aqueous mixture thereof at the pH of at least 9 for one day or more and subsequent adjustment of the pH to below 5.5, thereby precipitating substantially pure A.sub.4.
    Type: Grant
    Filed: March 13, 1978
    Date of Patent: May 29, 1979
    Assignee: Abbott Laboratories
    Inventor: Richard E. Crutcher
  • Patent number: D252470
    Type: Grant
    Filed: July 22, 1977
    Date of Patent: July 24, 1979
    Assignee: Abbott Laboratories
    Inventor: Kenneth E. Pawlak